This article highlights key challenges facing China in optimal use of medicines and suggests that in order to realize the value from medicines and to achieve the government's stated goal of providing "safe, effective, convenient, and affordable" medical service to Chinese patients, optimal use of high quality medicines has to be assured. It concludes with recommendations on public policy actions that can be taken to make progress toward achieving this goal.
While many in the global airline industry are rightfully concerned about the current recession, as well as the uncertainty surrounding how the industry becomes (appears to be) 'greener', there are some more fundamental issues that will severely test the business models of the industry.
No one will be surprised to learn that since 2007 premium class travel has dropped sharply. IATA reports a 25% fall in global business class passengers. And that figure is flattered by prices that have fallen almost 20%. For "full-service" carriers like Qantas and Air New Zealand, business class is critical to their profitability, with revenue per square meter in the premium cabins as much as three times that of economy.
In just a short period of time, China has become the global epicenter of solar cell and solar panel production. And China is about to become the largest base for wind-power generation, creating tremendous business opportunities for companies, both domestic and international.
This article considers a number of case examples of businesses that actively monitor their innovation performance and use it as an indicator of future success and value creation. Examples industries cited in the article include consumer products, electronics, industrial products and investment banking. The author then draws lessons that can be applied broadly across any business seeking to improve future growth and profitability through greater innovation.
